Abstract
New usnic acid (UA) derivatives were investigated in vitro to elucidate their potential inhibitory activities on the growth of Mycobacterium smegmatis and Mycobacterium tuberculosis. Seven pairs of enantiomers of thiazole UA derivatives were tested using the M. smegmatis strain mc2 155 test system, and the “structure–activity” relationship was established. The most active compounds were (+)-3 and (−)-3, and their kinase inhibitory activities were investigated. The results obtained using the Streptomyces lividans APHVIII+ and M. smegmatis APHVIII+ test systems indicated the significant protein kinase activity of these compounds and revealed the species specificity of the actions of the dextro- and levorotatory isomers. Both isomers, (+)-3 and (−)-3, possess similar inhibitory activity against M. tuberculosis H37Rv. The action of the isomers on eukaryotic cells was also investigated, and the results demonstrate that the dextrorotatory isomer (+)-3 leads to the lysis of intact macrophages to a degree higher than that obtained spontaneously and significantly higher than that obtained with the levorotatory isomer.
Similar content being viewed by others
References
Andries K, Verhasselt P, Guillemont J, Göhlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, Williams P, de Chaffoy D, Huitric E, Hoffner S, Cambau E, Truffot-Pernot C, Lounis N, Jarlier V (2005) A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307(5707):223–227
Balabanova Y, Radiulyte B, Davidaviciene E, Hooper R, Ignatyeva O, Nikolayevskyy V, Drobniewski FA (2011) Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study. Br Med J Open 1:e000351. doi:10.1136/bmjopen-2011-000351
Bekker OB, Elizarov SM, Alekseeva MT, Lyubimova IK, Danilenko VN (2008) Ca2+-dependent modulation of antibiotic resistance in Streptomyces lividans 66 and Streptomyces coelicolor A3 (2). Microbiology 77:559–567
Bekker OB, Alekseeva MG, Osolodkin DI, Palyulin VA, Elizarov SM, Zefirov NS, Danilenko VN (2010) New test system for serine/threonine protein kinase inhibitors screening: E. coli APHVIII/Pk25 design. Acta Nat 2:110–121
Blokpoel MCJ, Murphy HN, O’Toole R, Wiles S, Runn ESC, Stewart GR, Young DB, Robertson BD (2005) Tetracycline-inducible gene regulation in mycobacteria. Nucleic Acids Res 33:e22. doi:10.1093/nar/gni023
Casali N, Nikolayevskyy V, Balabanova Y, Ignatyeva O, Kontsevaya I, Harris SR, Bentley SD, Parkhill J, Nejentsev S, Hoffner SE, Horstmann RD, Brown T, Drobniewski F (2012) Microevolution of extensively drug-resistant tuberculosis in Russia. Genome Res 22:735–745
Cetin H, Tufan-Cetin O, Turk AO, Tay T, Candan M, Yanikoglu A, Sumbul H (2008) Insecticidal activity of major lichen compounds, (−)- and (+)-usnic acid, against the larvae of house mosquito, Culex pipiens L. Parasitol Res 102:1277–1279
Cocchietto M, Skert N, Nimis P, Sava G (2002) A review on usnic acid, an interesting natural compound. Naturwissenschaften 89:137–146
Danilenko V, Simonov A, Lakatosh S, Kubbutat M, Totzke F, Schaechtele C, Elizarov S, Bekker O, Printsevskaya S, Luzikov Y, Reznikova M, Shtil A, Preobrazhenskaya M (2008) Search for inhibitors of bacterial and human protein kinases among derivatives of diazepines[1,4] annelated with maleimide and indole cycles. J Med Chem 51:7731–7736
Danilenko VN, Osolodkin DI, Lakatosh SA, Preobrazhenskaya MN, Shtil AA (2011) Bacterial eukaryotic type serine–threonine protein kinases: from structural biology to targeted anti-infective drug design. Curr Top Med Chem 11:1352–1369
Dover LG, Coxon GD (2011) Current status and research strategies in tuberculosis drug development: miniperspective. J Med Chem 54:6157–6165
Elizarov SM, Alekseeva MG, Novikov FN, Chilov GG, Maslov DA, Shtil AA, Danilenko VN (2012) Identification of phosphorylation sites in aminoglycoside phosphotransferase VIII from Streptomyces rimosus. Biochemistry (Mosc) 77:1258–1265. doi:10.1134/S0006297912110041
Forrellad MA, Klepp LI, Gioffre A, Sabio y García GJ, Morbidoni HR, de la Paz Santangelo M, Cataldi AA, Bigi F (2013) Virulence factors of the Mycobacterium tuberculosis complex. Virulence 4:3–66
Honda NK, Pavan FR, Coelho RG, De Andrade Leite SR, Micheletti C, Lopes TIB, Misutsu MY, Beatriz A, Brum RL, Leite CQF (2010) Antimycobacterial activity of lichen substances. Phytomedicine 17:328–332
Koul A, Arnoult E, Lounis N, Guillemont J, Andries K (2011) The challenge of new drug discovery for tuberculosis. Nature 469:483–490
Leibert E, Danckers M, Rom WN (2014) New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline. Ther Clin Risk Manag 10:597–602. doi:10.2147/TCRM.S37743 eCollection
Liao JJ (2007) Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors. J Med Chem 50:409–424
Luzina OA, Sokolov DN, Shernyukov AV, Salakhutdinov NF (2012) Synthesis of aurones based on usninic acid. Chem Nat Compd 48:385–391
Matyugina E, Khandazhinskaya A, Chernousova L, Andreevskaya S, Smirnova T, Chizhov A, Karpenko I, Kochetkov S, Alexandrova L (2012) The synthesis and antituberculosis activity of 5′-nor carbocyclic uracil derivatives. Bioorg Med Chem 20:6680–6686
Meissner A, Boshoff HI, Vasan M, Duckworth BP, Barry CE III, Aldrich CC (2013) Structure–activity relationships of 2-aminothiazoles effective against Mycobacterium tuberculosis. Bioorg Med Chem 21:6385–6397
Polovinka MP, Salakhutdinov NF, Panchenko MY (2008) Russian Federation Patent 2317076
Prozorov AA, Zaichikova MV, Danilenko VN (2012) Mycobacterium tuberculosis mutants with multidrug resistance: history of origin, genetic and molecular mechanisms of resistance, and emerging challenges. Russ J Genet 48(1):1–14
Ramón-García S, Ng C, Anderson H, Chao JD, Zheng X, Pfeifer T, Av-Gay Y, Roberge M, Thompson CJ (2011) Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen. Antimicrob Agents Chemother 55:3861–3869
Riccardi G, Pasca MR (2014) Trends in discovery of new drugs for tuberculosis therapy. J Antibiot (Tokyo) 67(9):655–659. doi:10.1038/ja.2014.109
Siddiqi SH (2005) MGIT procedure manual for BACTEC MGIT 960 TB system. Becton Dickinson, Sparks, pp 81–84
Sokolov DN, Luzina OA, Salakhutdinov NF (2012) Usnic acid: preparation, structure, properties and chemical transformations. Russ Chem Rev 81:747–768
Thakur M, Chakraborti PK (2006) GTPase activity of mycobacterial FtsZ is impaired due to its transphosphorylation by the eukaryotic-type Ser/Thr kinase, PknA. J Biol Chem 281:40107–40113
Udwadia ZF (2012) MDR, XDR, TDR tuberculosis: ominous progression. Thorax 67:286–288
World Health Organization (2012) Global Tuberculosis Report
Zakharevich NV, Osolodkin DI, Artamonova II, Palyulin VA, Zefirov NS, Danilenko VN (2012) Signatures of the ATP-binding pocket as a basis for structural classification of the serine/threonine protein kinases of gram-positive bacteria. Proteins 80:1363–1376
Zhang Y, Yew WW (2009) Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 13:1320–1330
Zumla AI, Gillespie SH, Hoelscher M, Philips PP, Cole ST, Abubakar I, McHugh TD, Schito M, Maeurer M, Nunn AJ (2014) New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. Lancet Infect Dis 14(4):327–340. doi:10.1016/S1473-3099(13)70328-1
Acknowledgments
The study was supported by the Russian Foundation for Basic Research (Grant No. 13-03-00810) and Russia Federation Contract 2012 No. 12411.1008799.13.002.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bekker, O.B., Sokolov, D.N., Luzina, O.A. et al. Synthesis and activity of (+)-usnic acid and (−)-usnic acid derivatives containing 1,3-thiazole cycle against Mycobacterium tuberculosis . Med Chem Res 24, 2926–2938 (2015). https://doi.org/10.1007/s00044-015-1348-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-015-1348-2